Skip to main content
SpringerLink
Log in

Genetic Epidemiology Studies in Hereditary Non-Polyposis Colorectal Cancer

  • Protocol
Cancer Epidemiology

Part of the book series: Methods in Molecular Biology ((MIMB,volume 472))

Abstract

Genetic epidemiology studies in hereditary non-polyposis colorectal cancer (HNPCC) have the potential to radically improve assessment of disease risk such that more individualised information can be provided to patients susceptible to developing disease. Studies of HNPCC initially focused on disease associations and the definition of the disease and its association with different cancers within the context of an inherited predisposition. With the identification of the genetic basis of HNPCC, new insights into the disease have been forthcoming and many advances in our understanding have been made. There have been many reports examining potential modifier genes in HNPCC, yet the results remain controversial as many findings have not been replicated and therefore no clear consensus as to the role of specific modifier genes has been reached. This review focuses on some of the factors associated with disease risk in HNPCC and where some of the difficulties lie in assessing the value of genetic epidemiology studies in this disorder.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Watson, P. and H.T. Lynch, Extracolonic cancer in hereditary nonpolyposis colorectal cancer. Cancer, 1993. 71 (3): p. 677–685.

    Article  CAS  PubMed  Google Scholar 

  2. Lynch, H.T., S. Lanspa, T. Smyrk, B. Boman, P. Watson, and J. Lynch, Hereditary non-polyposis colorectal cancer (Lynch syndromes I & II). Genetics, pathology, natural history, and cancer control, Part I. Cancer Genet Cytogenet, 1991. 53 (2): p. 143–160.

    Article  CAS  PubMed  Google Scholar 

  3. Fishel, R., M.K. Lescoe, M.R. Rao, N.G. Copeland, N.A. Jenkins, J. Garber, M. Kane, and R. Kolodner, The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell, 1993. 75 (5): p. 1027–1038.

    Article  CAS  PubMed  Google Scholar 

  4. Nicolaides, N.C., N. Papadopoulos, B. Liu, Y.F. Wei, K.C. Carter, S.M. Ruben, C.A. Rosen, W.A. Haseltine, R.D. Fleischmann, C.M. Fraser, et al., Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature, 1994. 371 (6492): p. 75–80.

    Article  CAS  PubMed  Google Scholar 

  5. Bronner, C.E., S.M. Baker, P.T. Morrison, G. Warren, L.G. Smith, M.K. Lescoe, M. Kane, C. Earabino, J. Lipford, A. Lind-blom, et al., Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature, 1994. 368 (6468): p. 258–261.

    Article  CAS  PubMed  Google Scholar 

  6. Miyaki, M., M. Konishi, K. Tanaka, R. Kikuchi-Yanoshita, M. Muraoka, M. Yasuno, T. Igari, M. Koike, M. Chiba, and T. Mori, Germline mutation of MSH6 as the cause of hereditary nonpolyposis color-ectal cancer. Nat Genet, 1997. 17 (3): p. 271–272.

    Article  CAS  PubMed  Google Scholar 

  7. Liu, T., H. Yan, S. Kuismanen, A. Per-cesepe, M.L. Bisgaard, M. Pedroni, P. Ben-atti, K.W. Kinzler, B. Vogelstein, M. Ponz de Leon, P. Peltomaki, and A. Lindblom, The role of hPMS1 and hPMS2 in predisposing to colorectal cancer. Cancer Res, 2001. 61 (21): p. 7798–7802.

    CAS  PubMed  Google Scholar 

  8. Peltomaki, P., Role of DNA mismatch repair defects in the pathogenesis of human cancer. J Clin Oncol, 2003. 21 (6): p. 1174–1179.

    Article  CAS  PubMed  Google Scholar 

  9. Scott, R.J., M. McPhillips, C.J. Meldrum, P.E. Fitzgerald, K. Adams, A.D. Spigelman, D. du Sart, K. Tucker, and J. Kirk, Hereditary nonpolyposis colorectal cancer in 95 families: differences and similarities between mutation-positive and mutation-negative kindreds. Am J Hum Genet, 2001. 68 (1): p. 118–127.

    Article  CAS  PubMed  Google Scholar 

  10. Wijnen, J.T., H.F. Vasen, P.M. Khan, A.H. Zwinderman, H. van der Klift, A. Mulder, C. Tops, P. Moller, and R. Fodde, Clinical findings with implications for genetic testing in families with clustering of colorec-tal cancer. N Engl J Med, 1998. 339 (8): p. 511–518.

    Article  CAS  PubMed  Google Scholar 

  11. De Rosa, M., C. Fasano, L. Panariello, M.I. Scarano, G. Belli, A. Iannelli, F. Ciciliano, and P. Izzo, Evidence for a recessive inheritance of Turcot's syndrome caused by compound heterozygous mutations within the PMS2 gene. Oncogene, 2000. 19 (13): p. 1719–1723.

    Article  PubMed  Google Scholar 

  12. Hamilton, S.R., B. Liu, R.E. Parsons, N. Papadopoulos, J. Jen, S.M. Powell, A.J. Krush, T. Berk, Z. Cohen, B. Tetu, et al., The molecular basis of Turcot's syndrome. N Engl J Med, 1995. 332 (13): p. 839–847.

    Article  CAS  PubMed  Google Scholar 

  13. Felton, K.E., D.M. Gilchrist, and S.E. Andrew, Constitutive deficiency in DNA mismatch repair. Clin Genet, 2007. 71 (6): p. 483–498.

    Article  CAS  PubMed  Google Scholar 

  14. Felton, K.E., D.M. Gilchrist, and S.E. Andrew, Constitutive deficiency in DNA mismatch repair: is it time for Lynch III ? Clin Genet, 2007. 71 (6): p. 499–500.

    Article  CAS  PubMed  Google Scholar 

  15. Peltomaki, P., Deficient DNA mismatch repair: a common etiologic factor for colon cancer. Hum Mol Genet, 2001. 10 (7): p. 735–740.

    Article  CAS  PubMed  Google Scholar 

  16. Vasen, H.F., Y. Hendriks, A.E. de Jong, M. van Puijenbroek, C. Tops, A.H. Brocker-Vriends, J.T. Wijnen, and H. Morreau, Identification of HNPCC by molecular analysis of colorectal and endometrial tumors. Dis Markers, 2004. 20 (4–5): p. 207–213.

    CAS  PubMed  Google Scholar 

  17. Vasen, H.F., J.P. Mecklin, P.M. Khan, and H.T. Lynch, The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum, 1991. 34 (5): p. 424–425.

    Article  CAS  PubMed  Google Scholar 

  18. Fornasarig, M., A. Viel, E. Bidoli, E. Cam-pagnutta, A.M. Minisini, R. Cannizzaro, L. Della Puppa, and M. Boiocchi, Amsterdam criteria II and endometrial cancer index cases for an accurate selection of HNPCC families. Tumori, 2002. 88 (1): p. 18–20.

    PubMed  Google Scholar 

  19. Rodriguez-Bigas, M.A., C.R. Boland, S.R. Hamilton, D.E. Henson, J.R. Jass, P.M. Khan, H. Lynch, M. Perucho, T. Smyrk, L. Sobin, and S. Srivastava, A National Cancer Institute Workshop on Hereditary Nonpoly-posis Colorectal Cancer Syndrome: meeting highlights and Bethesda guidelines. J Natl Cancer Inst, 1997. 89 (23): p. 1758–1762.

    Article  CAS  PubMed  Google Scholar 

  20. Umar, A., C.R. Boland, J.P. Terdiman, S. Syngal, A. de la Chapelle, J. Ruschoff, R. Fishel, N.M. Lindor, L.J. Burgart, R. Hamelin, S.R. Hamilton, R.A. Hiatt, J. Jass, A. Lindblom, H.T. Lynch, P. Peltomaki, S.D. Ramsey, M.A. Rodriguez-Bigas, H.F. Vasen, E.T. Hawk, J.C. Barrett, A.N. Freedman, and S. Srivastava, Revised Bethesda Guidelines for hereditary nonpoly-posis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst, 2004. 96 (4): p. 261–268.

    Article  CAS  PubMed  Google Scholar 

  21. Kladny, J., G. Moeslein, T. Myrhoj, G. Kurzawski, A. Jakubowska, T. Debniak, W. Petriczko, M. Kozlowski, T. Al-Amawi, M. Brzosko, J. Flicinski, A. Jawien, Z. Banaszkiewicz, P. Rychter, and J. Lubin-ski, Nuclear Pedigree Criteria of Suspected HNPCC. Hereditary Cancer in Clinical Practice, 2003. 1.0 (1): p. 34–38.

    Google Scholar 

  22. Katballe, N., M. Christensen, F.P. Wikman, T.F. Orntoft, and S. Laurberg, Frequency of hereditary non-polyposis colorectal cancer in Danish colorectal cancer patients. Gut, 2002. 50 (1): p. 43–51.

    Article  CAS  PubMed  Google Scholar 

  23. Lamberti, C., E. Mangold, C. Pagenstecher, M. Jungck, D. Schwering, M. Bollmann, J. Vogel, D. Kindermann, R. Nikorowitsch, N. Friedrichs, B. Schneider, F. Housh-daran, I.G. Schmidt-Wolf, W. Friedl, P. Propping, T. Sauerbruch, R. Buttner, and M. Mathiak, Frequency of hereditary non-polyposis colorectal cancer among unselected patients with colorectal cancer in Germany. Digestion, 2006. 74 (1): p. 58–67.

    Article  CAS  PubMed  Google Scholar 

  24. Lynch, H.T. and A. de la Chapelle, Hereditary colorectal cancer. N Engl J Med, 2003. 348 (10): p. 919–932.

    Article  CAS  PubMed  Google Scholar 

  25. Dunlop, M.G., S.M. Farrington, A.D. Carothers, A.H. Wyllie, L. Sharp, J. Burn, B. Liu, K.W. Kinzler, and B. Vogelstein, Cancer risk associated with germline DNA mismatch repair gene mutations. Hum Mol Genet, 1997. 6 (1): p. 105–110.

    Article  CAS  PubMed  Google Scholar 

  26. Aarnio, M., J.P. Mecklin, L.A. Aaltonen, M. Nystrom-Lahti, and H.J. Jarvinen, Lifetime risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome. Int J Cancer, 1995. 64 (6): p. 430–433.

    Article  CAS  PubMed  Google Scholar 

  27. Vasen, H.F., J.T. Wijnen, F.H. Menko, J.H. Kleibeuker, B.G. Taal, G. Griffioen, F.M. Nagengast, E.H. Meijers-Heijboer, L. Bertario, L. Varesco, M.L. Bisgaard, J. Mohr, R. Fodde, and P.M. Khan, Cancer risk in families with hereditary nonpolypo-sis colorectal cancer diagnosed by mutation analysis. Gastroenterology, 1996. 110 (4): p. 1020–1027.

    Article  CAS  PubMed  Google Scholar 

  28. Voskuil, D.W., H.F. Vasen, E. Kampman, and P. van't Veer, Colorectal cancer risk in HNPCC families: development during lifetime and in successive generations. National Collaborative Group on HNPCC. Int J Cancer, 1997. 72 (2): p. 205–209.

    Article  CAS  PubMed  Google Scholar 

  29. Hampel, H., J.A. Stephens, E. Pukkala, R. Sankila, L.A. Aaltonen, J.P. Mecklin, and A. de la Chapelle, Cancer risk in hereditary nonpolyposis colorectal cancer syndrome: later age of onset. Gastroenterology, 2005. 129 (2): p. 415–421.

    PubMed  Google Scholar 

  30. Aarnio, M., R. Sankila, E. Pukkala, R. Salovaara, L.A. Aaltonen, A. de la Chapelle, P. Peltomaki, J.P. Mecklin, and H.J. Jarvinen, Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer, 1999. 81 (2): p. 214–218.

    Article  CAS  PubMed  Google Scholar 

  31. Carayol, J., M. Khlat, J. Maccario, and C. Bonaiti-Pellie, Hereditary non-polyposis colorectal cancer: current risks of colorectal cancer largely overestimated. J Med Genet, 2002. 39 (5): p. 335–339.

    Article  CAS  PubMed  Google Scholar 

  32. Parc, Y., C. Boisson, G. Thomas, and S. Ols-chwang, Cancer risk in 348 French MSH2 or MLH1 gene carriers. J Med Genet, 2003. 40 (3): p. 208–213.

    Article  CAS  PubMed  Google Scholar 

  33. Quehenberger, F., H.F. Vasen, and H.C. van Houwelingen, Risk of colorectal and endometrial cancer for carriers of mutations of the hMLH1 and hMSH2 gene: correction for ascertainment. J Med Genet, 2005. 42 (6): p. 491–496.

    Article  CAS  PubMed  Google Scholar 

  34. Alarcon, F., C. Lasset, J. Carayol, V. Bona-dona, H. Perdry, F. Desseigne, Q. Wang, and C. Bonaiti-Pellie, Estimating cancer risk in HNPCC by the GRL method. Eur J Hum Genet, 2007. 15 (8): p. 831–836.

    Article  CAS  PubMed  Google Scholar 

  35. Vasen, H.F., H. Morreau, and J.W. Nortier, Is breast cancer part of the tumor spectrum of hereditary nonpolyposis colorectal cancer ? Am J Hum Genet, 2001. 68 (6): p. 1533–1535.

    Article  CAS  PubMed  Google Scholar 

  36. Oliveira Ferreira, F., C.C. Napoli Ferreira, B.M. Rossi, W. Toshihiko Nakagawa, S. Aguilar, Jr., E.M. Monteiro Santos, M.L. Vierira Costa, and A. Lopes, Frequency of extra-colonic tumors in hereditary non-polyposis colorectal cancer (HNPCC) and familial colorectal cancer (FCC) Brazilian families: An analysis by a Brazilian Hereditary Colorectal Cancer Institutional Registry. Fam Cancer, 2004. 3 (1): p. 41–47.

    Article  PubMed  Google Scholar 

  37. Risinger, J.I., J.C. Barrett, P. Watson, H.T. Lynch, and J. Boyd, Molecular genetic evidence of the occurrence of breast cancer as an integral tumor in patients with the hereditary nonpolyposis colorectal carcinoma syndrome. Cancer, 1996. 77 (9): p. 1836–1843.

    Article  CAS  PubMed  Google Scholar 

  38. Boyd, J., E. Rhei, M.G. Federici, P.I. Borgen, P. Watson, B. Franklin, B. Karr, J. Lynch, S.J. Lemon, and H.T. Lynch, Male breast cancer in the hereditary nonpolyposis colorectal cancer syndrome. Breast Cancer Res Treat, 1999. 53 (1): p. 87–91.

    Article  CAS  PubMed  Google Scholar 

  39. de Leeuw, W.J., M. van Puijenbroek, R.A. Tollenaar, C.J. Cornelisse, H.F. Vasen, and H. Morreau, Correspondence re: A. Muller et al., Exclusion of breast cancer as an integral tumor of hereditary nonpolyposis colorectal cancer. Cancer Res., 62: 1014–1019, 2002. Cancer Res, 2003. 63 (5): p. 1148–1149.

    PubMed  Google Scholar 

  40. Watson, P. and B. Riley, The tumor spectrum in the Lynch syndrome. Fam Cancer, 2005. 4 (3): p. 245–248.

    Article  PubMed  Google Scholar 

  41. den Bakker, M.A., C. Seynaeve, M. Kliffen, and W.N. Dinjens, Microsatellite instability in a pleomorphic rhabdomyosarcoma in a patient with hereditary non-polyposis color-ectal cancer. Histopathology, 2003. 43 (3): p. 297–299.

    Article  Google Scholar 

  42. Vasen, H.F., A. Stormorken, F.H. Menko, F.M. Nagengast, J.H. Kleibeuker, G. Grif-fioen, B.G. Taal, P. Moller, and J.T. Wijnen, MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: a study of hereditary nonpolyposis colorec-tal cancer families. J Clin Oncol, 2001. 19 (20): p. 4074–4080.

    CAS  PubMed  Google Scholar 

  43. Bandipalliam, P., J. Garber, R.D. Kolodner, and S. Syngal, Clinical presentation correlates with the type of mismatch repair gene involved in hereditary nonpolyposis colon cancer. Gastroenterology, 2004. 126 (3): p. 936–937.

    Article  PubMed  Google Scholar 

  44. Bandipalliam, P., Variability in the clinical phenotype among families with HNPCC— the potential importance of the location of the mutation in the gene. Int J Cancer, 2007. 120 (10): p. 2275–2277; author reply 2278.

    Article  CAS  PubMed  Google Scholar 

  45. Hayward, B.E., M. De Vos, E. Sheridan, and D.T. Bonthron, PMS2 mutations in HNPCC. Clin Genet, 2004. 66 (6): p. 566–567; author reply 568.

    Article  CAS  PubMed  Google Scholar 

  46. De Vos, M., B.E. Hayward, S. Picton, E. Sheridan, and D.T. Bonthron, Novel PMS2 pseudogenes can conceal recessive mutations causing a distinctive childhood cancer syndrome. Am J Hum Genet, 2004. 74 (5): p. 954–964.

    Article  PubMed  Google Scholar 

  47. Hendriks, Y.M., A. Wagner, H. Morreau, F. Menko, A. Stormorken, F. Quehenberger, L. Sandkuijl, P. Moller, M. Genuardi, H. Van Houwelingen, C. Tops, M. Van Pui-jenbroek, P. Verkuijlen, G. Kenter, A. Van Mil, H. Meijers-Heijboer, G.B. Tan, M.H. Breuning, R. Fodde, J.T. Wijnen, A.H. Brocker-Vriends, and H. Vasen, Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations: impact on counseling and surveillance. Gastroenterology, 2004. 127 (1): p. 17–25.

    Article  CAS  PubMed  Google Scholar 

  48. Kolodner, R.D., J.D. Tytell, J.L. Schmeits, M.F. Kane, R.D. Gupta, J. Weger, S. Wahlberg, E.A. Fox, D. Peel, A. Ziogas, J.E. Garber, S. Syngal, H. Anton-Culver, and F.P. Li, Germ-line msh6 mutations in colorectal cancer families. Cancer Res, 1999. 59 (20): p. 5068–5074.

    CAS  PubMed  Google Scholar 

  49. Plaschke, J., C. Engel, S. Kruger, E. Holin-ski-Feder, C. Pagenstecher, E. Mangold, G. Moeslein, K. Schulmann, J. Gebert, M. von Knebel Doeberitz, J. Ruschoff, M. Loeffler, and H.K. Schackert, Lower incidence of colorectal cancer and later age of disease onset in 27 families with pathogenic MSH6 germline mutations compared with families with MLH1 or MSH2 mutations: the German Hereditary Nonpolyposis Color-ectal Cancer Consortium. J Clin Oncol, 2004. 22 (22): p. 4486–4494.

    Article  CAS  PubMed  Google Scholar 

  50. Wijnen, J., W. de Leeuw, H. Vasen, H. van der Klift, P. Moller, A. Stormorken, H. Meijers-Heijboer, D. Lindhout, F. Menko, S. Vossen, G. Moslein, C. Tops, A. Brocker-Vriends, Y. Wu, R. Hofstra, R. Sijmons, C. Cornelisse, H. Morreau, and R. Fodde, Familial endometrial cancer in female carriers of MSH6 germline mutations. Nat Genet, 1999. 23 (2): p. 142–144.

    Article  CAS  PubMed  Google Scholar 

  51. Mary, J.L., T. Bishop, R. Kolodner, J.R. Lip-ford, M. Kane, W. Weber, J. Torhorst, H. Muller, M. Spycher, and R.J. Scott, Muta-tional analysis of the hMSH2 gene reveals a three base pair deletion in a family predisposed to colorectal cancer development. Hum Mol Genet, 1994. 3 (11): p. 2067–2069.

    CAS  PubMed  Google Scholar 

  52. Moisio, A.L., P. Sistonen, J.P. Mecklin, H. Jarvinen, and P. Peltomaki, Genetic polymorphisms in carcinogen metabolism and their association to hereditary nonpoly-posis colon cancer. Gastroenterology, 1998. 115 (6): p. 1387–1394.

    Article  CAS  PubMed  Google Scholar 

  53. Brown, S.R., P.J. Finan, and D.T. Bishop, Are relatives of patients with multiple HNPCC spectrum tumours at increased risk of cancer ? Gut, 1998. 43 (5): p. 664–668.

    Article  CAS  PubMed  Google Scholar 

  54. Talseth, B.A., C. Meldrum, J. Suchy, G. Kurzawski, J. Lubinski, and R.J. Scott, Lack of association between genetic polymorphisms in cytokine genes and disease expression in patients with hereditary non-polyposis colorectal cancer. Scand J Gastroenterol, 2007. 42 (5): p. 628–632.

    Article  CAS  PubMed  Google Scholar 

  55. Talseth, B.A., C. Meldrum, J. Suchy, G. Kurzawski, J. Lubinski, and R.J. Scott, Genetic polymorphisms in xenobiotic clearance genes and their influence on disease expression in hereditary nonpolyposis color-ectal cancer patients. Cancer Epidemiol Biomarkers Prev, 2006. 15 (11): p. 2307–2310.

    Article  CAS  PubMed  Google Scholar 

  56. Shin, J.H., J.L. Ku, K.H. Shin, Y.K. Shin, S.B. Kang, and J.G. Park, Glutathione S-transferase M1 associated with cancer occurrence in Korean HNPCC families carrying the hMLH1/hMSH2 mutation. Oncol Rep, 2003. 10 (2): p. 483–486.

    CAS  PubMed  Google Scholar 

  57. Bala, S. and P. Peltomaki, CYCLIN D1 as a genetic modifier in hereditary nonpoly-posis colorectal cancer. Cancer Res, 2001. 61 (16): p. 6042–6045.

    CAS  PubMed  Google Scholar 

  58. Chen, J., S. Sen, C.I. Amos, C. Wei, J.S. Jones, P. Lynch, and M.L. Frazier, Associa tion between Aurora-A kinase polymorphisms and age of onset of hereditary nonpolyposis colorectal cancer in a Caucasian population. Mol Carcinog, 2007. 46 (4): p. 249–256.

    Article  CAS  PubMed  Google Scholar 

  59. Heinimann, K., R.J. Scott, P. Chappuis, W. Weber, H. Muller, Z. Dobbie, and P. Hutter, N-acetyltransferase 2 influences cancer prevalence in hMLH1/hMSH2 mutation carriers. Cancer Res, 1999. 59 (13): p. 3038–3040.

    CAS  PubMed  Google Scholar 

  60. Pistorius, S., H. Goergens, C. Engel, J. Plaschke, S. Krueger, R. Hoehl, H.D. Saeger, and H.K. Schackert, N-Acetyltrans-ferase (NAT) 2 acetylator status and age of tumour onset in patients with sporadic and familial, microsatellite stable (MSS) color-ectal cancer. Int J Colorectal Dis, 2007. 22 (2): p. 137–143.

    Article  PubMed  Google Scholar 

  61. Frazier, M.L., F.T. O'Donnell, S. Kong, X. Gu, I. Campos, R. Luthra, P.M. Lynch, and C.I. Amos, Age-associated risk of cancer among individuals with N-acetyltrans-ferase 2 (NAT2) mutations and mutations in DNA mismatch repair genes. Cancer Res, 2001. 61 (4): p. 1269–1271.

    CAS  PubMed  Google Scholar 

  62. Ketterer, B., Protective role of glutathione and glutathione transferases in mutagen-esis and carcinogenesis. Mutat Res, 1988. 202 (2): p. 343–361.

    CAS  PubMed  Google Scholar 

  63. Helzlsouer, K.J., O. Selmin, H.Y. Huang, P.T. Strickland, S. Hoffman, A.J. Alberg, M. Watson, G.W. Comstock, and D. Bell, Association between glutathione S-trans-ferase M1, P1, and T1 genetic polymorphisms and development of breast cancer. J Natl Cancer Inst, 1998. 90 (7): p. 512–518.

    Article  CAS  PubMed  Google Scholar 

  64. Felix, R., W. Bodmer, N.S. Fearnhead, L. van der Merwe, P. Goldberg, and R.S. Ramesar, GSTM1 and GSTT1 polymorphisms as modifiers of age at diagnosis of hereditary nonpolyposis colorectal cancer (HNPCC) in a homogeneous cohort of individuals carrying a single predisposing mutation. Mutat Res, 2006. 602 (1–2): p. 175–181.

    CAS  PubMed  Google Scholar 

  65. Campbell, P.T., L. Edwards, J.R. McLaughlin, J. Green, H.B. Younghusband, and M.O. Woods, Cytochrome P450 17A1 and catechol O-methyltransferase polymorphisms and age at Lynch syndrome colon cancer onset in Newfoundland. Clin Cancer Res, 2007. 13 (13): p. 3783–3788.

    Article  CAS  PubMed  Google Scholar 

  66. Esteller, M., A. Garcia, J.M. Martinez-Pal-ones, J. Xercavins, and J. Reventos, Germ line polymorphisms in cytochrome-P450 1A1 (C4887 CYP1A1) and methylenetetrahy-drofolate reductase (MTHFR) genes and endometrial cancer susceptibility. Carcino-genesis, 1997. 18 (12): p. 2307–2311.

    Article  CAS  Google Scholar 

  67. Zhang, Z.W., P. Newcomb, A. Hollowood, R. Feakins, M. Moorghen, A. Storey, M.J. Farthing, D. Alderson, and J. Holly, Age-associated increase of codon 72 Arginine p53 frequency in gastric cardia and non-cardia adenocarcinoma. Clin Cancer Res, 2003. 9 (6): p. 2151–2156.

    CAS  PubMed  Google Scholar 

  68. Bougeard, G., S. Baert-Desurmont, I. Tournier, S. Vasseur, C. Martin, L. Brugieres, A. Chompret, B. Bressac-de Paillerets, D. Stoppa-Lyonnet, C. Bonaiti-Pellie, and T. Frebourg, Impact of the MDM2 SNP309 and p53 Arg72Pro polymorphism on age of tumour onset in Li-Fraumeni syndrome. J Med Genet, 2006. 43 (6): p. 531–533.

    Article  CAS  PubMed  Google Scholar 

  69. Talseth, B.A., C. Meldrum, J. Suchy, G. Kurzawski, J. Lubinski, and R.J. Scott, Age of diagnosis of colorectal cancer in HNPCC patients is more complex than that predicted by R72P polymorphism in TP53. Int J Cancer, 2006. 118 (10): p. 2479–2484.

    Article  CAS  PubMed  Google Scholar 

  70. Talseth, B.A., C. Meldrum, J. Suchy, G. Kurzawski, J. Lubinski, and R.J. Scott, MDM2 SNP309 T <G alone or in combination with the TP53 R72P polymorphism does not appear to influence disease expression and age of diagnosis of colorectal cancer in HNPCC patients. Int J Cancer, 2007. 120 (3): p. 563–565.

    Article  CAS  PubMed  Google Scholar 

  71. Sotamaa, K., S. Liyanarachchi, J.P. Meck-lin, H. Jarvinen, L.A. Aaltonen, P. Pelto-maki, and A. de la Chapelle, p53 codon 72 and MDM2 SNP309 polymorphisms and age of colorectal cancer onset in Lynch syndrome. Clin Cancer Res, 2005. 11 (19 Pt 1): p. 6840–6844.

    Article  CAS  PubMed  Google Scholar 

  72. Kong, S., C.I. Amos, R. Luthra, P.M. Lynch, B. Levin, and M.L. Frazier, Effects of cyclin D1 polymorphism on age of onset of hereditary nonpolyposis colorectal cancer. Cancer Res, 2000. 60 (2): p. 249–252.

    CAS  PubMed  Google Scholar 

  73. Kruger, S., C. Engel, A. Bier, E. Mangold, C. Pagenstecher, M.K. Doeberitz, E. Holinski-Feder, G. Moeslein, G. Keller, E. Kunstmann, W. Friedl, J. Plaschke, J. Ruschoff, and H.K. Schackert, Absence of association between cyclin D1 (CCND1) G870A polymorphism and age of onset in hereditary nonpolyposis colorectal cancer. Cancer Lett, 2006. 236 (2): p. 191–197.

    Article  PubMed  Google Scholar 

  74. Talseth, B.A., K.A. Ashton, C. Meldrum, J. Suchy, G. Kurzawski, J. Lubinski, and R.J. Scott. Aurora-A and Cyclin D1 polymorphisms and the age of onset of colorectal cancer in hereditary nonpolyposis colorectal cancer. Int. J. Cancer, 2008. 122 : p1273–1277.

    Article  Google Scholar 

  75. Maillet, P., P.O. Chappuis, G. Vaudan, Z. Dobbie, H. Muller, P. Hutter, and A.P. Sappino, A polymorphism in the ATM gene modulates the penetrance of hereditary non-polyposis colorectal cancer. Int J Cancer, 2000. 88 (6): p. 928–931.

    Article  CAS  PubMed  Google Scholar 

  76. Jones, J.S., X. Gu, P.M. Lynch, M. Rod-riguez-Bigas, C.I. Amos, and M.L. Frazier, ATM polymorphism and hereditary nonpoly-posis colorectal cancer (HNPCC) age of onset (United States). Cancer Causes Control, 2005. 16 (6): p. 749–753.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Discipline of Medical Genetics, School of Biomedical Sciences, University of Newcastle and the Hunter Medical Research Institute, Newcastle New South Wales, Australia

    Rodney J. Scott (Faculty of Health)

  2. International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland

    Jan Lubinski

Authors
  1. Rodney J. Scott
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jan Lubinski
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, Maryland, 20892, USA

    Mukesh Verma PhD

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer Science+Business Media, LLC

About this protocol

Cite this protocol

Scott, R.J., Lubinski, J. (2009). Genetic Epidemiology Studies in Hereditary Non-Polyposis Colorectal Cancer. In: Verma, M. (eds) Cancer Epidemiology. Methods in Molecular Biology, vol 472. Humana Press. https://doi.org/10.1007/978-1-60327-492-0_4

Download citation

  • DOI: https://doi.org/10.1007/978-1-60327-492-0_4

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-60327-491-3

  • Online ISBN: 978-1-60327-492-0

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics

Search

Navigation